在癌症免疫治疗中TCR交叉反应的意想不到的好处
Florian Bieberich1, Sai T Reddy1
1Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
Cancer research
|September 5, 2023
概括
来自瘤透淋巴细胞 (TIL) 的某些T细胞受体 (TCR) 显示出有益的交叉反应性,识别多个瘤相关抗原 (TAA). 这一发现为向癌症免疫疗法和改善癌细胞根除提供了新的优势.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
- 分子生物学分子生物学
背景情况:
- 收养T细胞疗法,包括瘤透性淋巴细胞 (TIL) 转移,依赖于T细胞受体 (TCRs) 识别瘤相关抗原 (TAAs).
- TCR交叉活性,即结合多个抗原的能力,通常被视为开发基于TCR的向癌症免疫疗法的局限性.
研究的目的:
- 在成功的癌症免疫治疗的背景下,研究TCR交叉反应的作用.
- 确定针对瘤相关抗原 (TAA) 的TCR存在有益的交叉活性.
- 阐明TCR交叉反应对癌细胞根除的影响及其对未来癌症治疗的潜力.
主要方法:
- 从响应治疗的黑色素瘤患者的TILs中分离和描述TCRs.
- 对TCR结合亲和力和特异性的评估与TAA小组对比.
- 对TCR交叉反应对T细胞间接杀死癌细胞的功能后果的评估.
主要成果:
- 从有效的TIL治疗中分离出来的某些TCR显示出交叉反应性,识别多个TAA.
- 这种有益的交叉活性与增强的癌细胞根除有关.
- 该研究确定了具有有利的交叉反应性概况的特定TCR.
结论:
- TCR交叉反应性并不总是局限性,并且可以在癌症免疫治疗中成为有益的特征.
- 利用有益的TCR交叉反应性为开发更有效的向癌症免疫疗法提供了一个有希望的策略.
- 对TCR交叉反应性的进一步研究可能会导致癌症治疗中患者的治疗结果得到改善.
更多相关视频
08:04In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function
Published on: February 27, 2019
11.8K
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
3.4K
相关概念视频
Cross-reactivity
31.2K
Overview
31.2K
Tumor Immunotherapy
555
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
555
Cytotoxic T Cells-mediated Immune Response
963
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
963
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
T Cell Activation and Clonal Selection
804
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
804
Diversity of Antigen Receptors
630
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
630
